本页面由Tiger Trade Technology Pte. Ltd.提供服务

ANI Pharmaceuticals, Inc.

75.35
-1.9700-2.55%
盘后75.350.00000.00%19:39 EDT
成交量:37.92万
成交额:2,868.69万
市值:17.31亿
市盈率:16.60
高:77.81
开:77.33
低:74.81
收:77.32
52周最高:99.50
52周最低:70.15
股本:2,297.04万
流通股本:2,028.20万
量比:1.41
换手率:1.87%
股息:- -
股息率:- -
每股收益(TTM):4.54
每股收益(LYR):3.32
净资产收益率:20.46%
总资产收益率:5.45%
市净率:2.90
市盈率(LYR):22.70

数据加载中...

2026/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/07

重要事件披露

Form 8-K - Current report
2026/07/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/28

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/17

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/13

重要事件披露

Form 8-K - Current report
2026/05/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/08

重要事件披露

Form 8-K - Current report
2026/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/07

重要事件披露

Form 8-K - Current report
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

重要事件披露

Form 8-K - Current report
2026/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]